Neither money nor other nudges are enough to persuade vaccine-hesitant people to get the COVID-19 vaccine, a new USC study shows. The findings, published recently in the journal Vaccine, suggest the standard public...
A new digital health study by researchers at Scripps Research shows how data from wearable sensors, such as smartwatches and fitness bands, can track a person’s physiological response to the COVID-19 vaccination. The...
The fourth wave of the COVID-19 pandemic is putting pressure on hospital networks, upsetting many and making vaccine refusals seem foolish. To better understand what leads someone refuse or delay vaccination, it is...
In a significant move to combat the Covid-19 pandemic, the U.S. government agreed to support a controversial proposal to temporarily waive intellectual property rights for vaccines in a bid to increase global supplies...
Bharat Biotech has reported that interim analysis results from the Phase III trial of its Covid-19 vaccine COVAXIN showed a 100% efficacy against severe SARS-CoV-2 infection and has an impact on the drop in...
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce. Experts estimate that 80 percent of people in low-resource countries will not receive a...
A federally funded study taking place at 21 college campuses will test how well Moderna’s COVID-19 shot prevents vaccinated people from spreading the coronavirus, The Washington Post reported. Clinical trials have...
People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination. However, stronger cellular (T cell) responses were seen in...
Unless someone has an unusual medical condition that would render vaccination contraindicated, the short answer is yes, it is unethical to refuse to get vaccinated against COVID-19. I am not a doctor, nor a philosopher...
An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial data and shared its interim analysis with the trial oversight...